{"groups":[{"description":"Patients receive gallium Ga 68-edotreotide IV and undergo PET/CT scan. Within 120 days, patients undergo standard indium In 111 pentetreotide contrast-enhanced CT or MRI scan. Patients may undergo a second gallium Ga 68-edotreotide PET/CT scan within 3-6 months if the lesions of the first scan cannot be confirmed.\n\ngallium Ga 68-edotreotide: Given IV\n\npositron emission tomography/computed tomography: Undergo gallium Ga 68-edotreotide PET/CT scan\n\nindium In 111 pentetreotide: Undergo indium In 111 pentetreotide contrast-enhanced CT or MRI scan\n\ncomputed tomography: Undergo indium In 111 pentetreotide contrast-enhanced CT scan\n\ncontrast-enhanced magnetic resonance imaging: Undergo indium In 111 pentetreotide contrast-enhanced CT or MRI scan","id":"FG000","title":"Diagnostic (Gallium Ga 68-edotreotide PET/CT)"}],"periods":[{"dropWithdraws":[{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"ineligible after registration"},{"reasons":[{"groupId":"FG000","numSubjects":"1"}],"type":"Death"},{"reasons":[{"groupId":"FG000","numSubjects":"2"}],"type":"Lost to Follow-up"}],"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"68"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"64"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"4"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}